SCHEMBL6154385

SCHEMBL6154385

CCOB(OCC)OCC.[LiH]

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL50777 0.96 ALDH1A1 (0.32) ALDH1A1
SCHEMBL27913833 0.96 ALDH1A1 (0.32) ALDH1A1
SCHEMBL3041911 0.92 ALDH1A1 (0.30) ALDH1A1
SCHEMBL1056384 0.92 ALDH1A1 (0.30) ALDH1A1
Water SCHEMBL28116863 0.92 ALDH1A1 (0.30) ALDH1A1
Fluoride SCHEMBL23120036 0.92 ALDH1A1 (0.30) ALDH1A1
Ammonia Solution, Strong SCHEMBL9328292 0.92 ALDH1A1 (0.30) ALDH1A1
SCHEMBL10843317 0.88
Lithium Ion SCHEMBL10846050 0.88
Dimethylamine SCHEMBL3618358 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114478336-B Process for producing mercaptophenol compound and intermediate therefor 组合化学工业株式会社 2024-05-14 CN disclosed
CN-115279774-A Novel borate compound-containing compositions AGC株式会社 2022-11-01 CN disclosed
CN-108496259-B Composition, phosphorescent compound and light-emitting element 住友化学株式会社 2020-03-03 CN disclosed
EP-3209296-B1 ETHYL N-BOC PIPERIDINYL PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS MERCK SHARP & DOHME (US) 2019-07-10 EP disclosed
US-10123978-B2 Patch for treating dermatophytosis MEIJI SEIKA PHARMA CO., LTD. (JP) 2018-11-13 US disclosed
US-10072025-B2 Ethyl N-boc piperidinyl pyrazolo pyridones as Janus kinase inhibitors MERCK SHARP & DOHME CORP. (US) 2018-09-11 US disclosed
EP-2881114-B1 ANTI-TRICHOPHYTIC ADHESIVE PATCH MEIJI SEIKA PHARMA CO LTD (JP) 2018-09-05 EP disclosed
US-20180200199-A1 PATCH FOR TREATING DERMATOPHYTOSIS MEIJI SEIKA PHARMA CO., LTD. (JP) 2018-07-19 US disclosed
EP-3209296-A1 ETHYL N-BOC PIPERIDINYL PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS Merck Sharp & Dohme Corp. (US) 2017-08-30 EP disclosed
US-20170240567-A1 ETHYL N-BOC PIPERIDINYL PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2017-08-24 US disclosed
EP-2889031-A1 ANTITRICHOPHYTOSIS SOLUTION FOR EXTERNAL USE Meiji Seika Pharma Co., Ltd. (JP) 2015-07-01 EP disclosed
EP-2881114-A1 ANTI-TRICHOPHYTIC ADHESIVE PATCH Meiji Seika Pharma Co., Ltd. (JP) 2015-06-10 EP disclosed
US-20140030209-A1 TOPICAL LIQUID AGENT FOR THE TREATMENT OF DERMATOPHYTOSIS MEIJI SEIKA PHARMA CO., LTD. (JP) 2014-01-30 US disclosed
US-20050165185-A1 Preparation of a conjugated molecule and materials for use therein MERCK PATENT GMBH (DE) 2005-07-28 US disclosed
EP-1499662-A1 PREPATION OF A CONJUGATED MOLECULE AND MATERIALS FOR USE THEREIN Avecia Limited (GB) 2005-01-26 EP disclosed
WO-2003089499-A1 PREPATION OF A CONJUGATED MOLECULE AND MATERIALS FOR USE THEREIN AVECIA LIMITED (GB) 2003-10-30 WO disclosed
CN-1017892-B PURE ENANTIOMERS OF 4,5-DISUBSTITUTED R-BUTYROLACTAMS, PROCESS FOR THEIR PREPARATION AND THEIR USE BAYER AG (DE) 1992-08-19 CN disclosed
CN-87103770-A 4,5 two replace the pure enantiomorph of butyrolactam, their preparation method and application 1988-02-03 CN disclosed
US-4578482-A Process for preparing prostacyclins TEIJIN LIMITED (JP) 1986-03-25 US disclosed
EP-0113577-A1 Process for preparing prostacyclins TEIJIN LIMITED (JP) 1984-07-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180200199-A1 PATCH FOR TREATING DERMATOPHYTOSIS DPM1, KRT18, LCP1 ALDH1A1 3414/4885
US-10123978-B2 Patch for treating dermatophytosis DPM1, KRT18, LCP1 ALDH1A1 3414/4885
US-20170240567-A1 ETHYL N-BOC PIPERIDINYL PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS JAK1, JAK2, JAK3 ALDH1A1 2779/4885
US-10072025-B2 Ethyl N-boc piperidinyl pyrazolo pyridones as Janus kinase inhibitors JAK1, JAK2, JAK3 ALDH1A1 2779/4885
US-20140030209-A1 TOPICAL LIQUID AGENT FOR THE TREATMENT OF DERMATOPHYTOSIS POLR1C, CUTA, C1R ALDH1A1 2643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.